PROM1 and ataxia telangiectasia: Stratified analysis showed that in subgroups with or without AT, CD133High patients had poorer clinical outcomes as compared to CD133Low patients, indicating that the prognostic significance of CD133 expression in CRC patients was not influenced by the intervention of postoperative adjuvant therapy.